Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
| Current Price | ₹725.50 |
|---|---|
| Market Cap | ₹14,261 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Non-Prescription Drugs |
| P/E Ratio | 21.1 |
| Return on Equity | 12.36% |
| 52-Week Range | ₹635.80 – ₹1,107.90 |
| Beta (1Y) | 0.42 |
| Dividend Yield | 1.65% |
1. Pharmaceuticals-100%
Alembic Pharmaceuticals Limited (Aplltd) is trading at ₹725.50, with a market capitalisation of ₹14,261 Cr.
Alembic Pharmaceuticals Limited (Aplltd) operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).
Alembic Pharmaceuticals Limited (Aplltd) has a P/E of 21.1 and a return on equity of 12.36%.